MENU

ALXO ALX Oncology Holdings Forecast, Technical & Fundamental Analysis

a clinical stage company, which engages in the research and development of therapies for cancer patients

Industry Biotechnology
ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ALXO is expected to report earnings to rise 17.24% to -68 cents per share on March 06

ALX Oncology Holdings ALXO Stock Earnings Reports
Q4'24
Est.
$-0.68
Q3'24
Beat
by $0.20
Q2'24
Missed
by $0.02
Q1'24
Beat
by $0.11
Q4'23
Missed
by $0.05
The last earnings report on November 08 showed earnings per share of -57 cents, beating the estimate of -77 cents. With 2.14M shares outstanding, the current market capitalization sits at 94.41M.
A.I. Advisor
published General Information

General Information

a clinical stage company, which engages in the research and development of therapies for cancer patients

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
323 Allerton Avenue
Phone
+1 650 466-7125
Employees
72
Web
https://www.alxoncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ALXO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALXO has been loosely correlated with MRNA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ALXO jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALXO
1D Price
Change %
ALXO100%
+16.23%
MRNA - ALXO
39%
Loosely correlated
-2.58%
BPMC - ALXO
35%
Loosely correlated
+1.14%
ALLO - ALXO
35%
Loosely correlated
+0.49%
CRBU - ALXO
34%
Loosely correlated
+1.57%
PGEN - ALXO
34%
Loosely correlated
+2.46%
More